Kolexia
Lemee Veronique
Pharmacien
Hôpital Charles Nicolle
Rouen, France
47 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à VIH COVID-19 Hépatite Sepsie Infections à échovirus Morsures et piqûres Giardiase Entorses et foulures Virémie

Industries

MSD
2 collaboration(s)
Dernière en 2022
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Evaluation of the ELITechGroup solution for plasma HIV-1 RNA quantification
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology   03 mars 2024
Re: First evidence of a mother-to-child transmission of an HIV-1/MO intergroup recombinant form.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases   21 février 2024
Efficacy of Tixagevimab/Cilgavimab Prophylaxis and Vaccination on Omicron Variants (BA.1, BA.2, BA.5, and BQ.1.1) in Kidney Transplant Recipients.
Clinical journal of the American Society of Nephrology : CJASN   29 juin 2023
Severe and fatal neonatal infections linked to a new variant of echovirus 11, France, July 2022 to April 2023.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin   05 juin 2023
Humoral response to a fourth dose of mRNA vaccine in kidney transplant recipient responders to three doses of mRNA vaccine.
Clinical kidney journal   02 août 2022
Efficacy of anti-SARS-CoV-2 monoclonal antibody prophylaxis and vaccination on the Omicron variant of COVID-19 in kidney transplant recipients.
Kidney international   23 mai 2022
Dissociated humoral and cellular immune responses after a three-dose schema of BNT162b2 vaccine in patients receiving anti-CD20 monoclonal antibody maintenance treatment for B-cell lymphomas.
Haematologica   01 mars 2022
Waning antibody response and cellular immunity 6 months after third dose SARS-Cov-2 mRNA BNT162b2 vaccine in kidney transplant recipients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons   28 janvier 2022
HIV1 group M superinfection in a HIV1 group0-infected patient.
Virologie (Montrouge, France)   04 novembre 2021
Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients.
Kidney international   04 octobre 2021